Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other Non-Current Liabilities: 2024

Historic Other Non-Current Liabilities for Crinetics Pharmaceuticals (CRNX) over the last 1 years, with Dec 2024 value amounting to $829,000.

  • Crinetics Pharmaceuticals' Other Non-Current Liabilities rose 466.34% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 466.34%. This contributed to the annual value of $829,000 for FY2024, which is N/A change from last year.
  • Crinetics Pharmaceuticals' Other Non-Current Liabilities amounted to $829,000 in FY2024.
  • In the past 5 years, Crinetics Pharmaceuticals' Other Non-Current Liabilities registered a high of $829,000 during FY2024, and its lowest value of $829,000 during FY2024.
  • For the 1-year period, Crinetics Pharmaceuticals' Other Non-Current Liabilities averaged around $829,000, with its median value being $829,000 (2024).